Evelo Biosciences upgraded by Chardan Capital Markets with a new price target
$EVLO
Biotechnology: Pharmaceutical Preparations
Health Care
Chardan Capital Markets upgraded Evelo Biosciences from Neutral to Buy and set a new price target of $12.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/2/2021 | $44.00 → $41.50 | Market Outperform | JMP Securities |
| 11/1/2021 | $12.00 | Neutral → Buy | Chardan Capital Markets |
| 6/23/2021 | $36.00 → $38.00 | Market Outperform | JMP Securities |
| 6/23/2021 | $28.00 | Overweight | Cantor Fitzgerald |